Status:
COMPLETED
Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Conditions:
COVID-19
Myocardial Injury
Eligibility:
All Genders
16+ years
Brief Summary
COVID-19 outbreak is often lethal. Mortality has been associated with several cardio-vascular risk factors such as diabetes, obesity, hypertension and tobacco use. Other clinico-biological features pr...
Eligibility Criteria
Inclusion
- \- COVID-19 positive patients admitted in a ward identified by positive PCR on nasal swab samples
Exclusion
- \- Patients who refused the use of their routine care data after information by investigators.
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 20 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04320017
Start Date
March 20 2020
End Date
July 20 2020
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Investigation Center Pitié-Salpêtrière
Paris, France, 75013